Nucleotide excision repair is impaired by binding of transcription factors to DNA
Radhakrishnan SabarinathaniD, Loris MularoniiD, Jordi Deu-PonsiD, Abel Gonzalez-Perez, Nuria Lopez-Bigas
Abstract
Somatic mutations are the driving force of cancer genome evolution1. The rate of somatic mutations appears in great variability across the genome due to chromatin organization, DNA accessibility and replication timing2-5. However, other variables that may influence the mutation rate locally, such as DNA-binding proteins, are unknown. Here we demonstrate that the rate of somatic mutations in melanoma tumors is highly increased at active Transcription Factor binding sites (TFBS) and nucleosome embedded DNA, compared to their flanking regions. Using recently available excision-repair sequencing (XR-seq) data6, we show that the higher mutation rate at these sites is caused by a decrease of the levels of nucleotide excision repair (NER) activity. Therefore, our work demonstrates that DNA-bound proteins interfere with the NER machinery, which results in an increased rate of mutations at their binding sites. This finding has important implications in our understanding of mutational and DNA repair processes and in the identification of cancer driver mutations.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A pan-cancer catalog of mutagenesis at transcription factor binding sites
Harshit Sahay, Yuncheng Duan, Raluca Gordân·bioRxiv·Oct 20, 2026
- UV irradiation remodels the specificity landscape of transcription factors
- Transcription factor co-occupancy shapes the somatic mutational landscapes across regulatory regions in liver cancer
Nija George, Anurag Kumar Singh, Radhakrishnan Sabarinathan·bioRxiv·Aug 25, 2026
- Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes
Christian A. Lee, Diala Abd-Rabbo, Jüri Reimand·Genome biologyPeer-reviewed·May 3, 2021
- Therapy-associated mutagenesis at CTCF binding sites is shaped by chromatin context and DNA repair capacity
Kevin C.L. Cheng, Zoe P. Klein, … Jüri Reimand·bioRxiv·Apr 18, 2026
- DNA replication initiation drives focal mutagenesis and rearrangements in human cancers
Pierre Murat, Guillaume Guilbaud, Julian E. Sale·Nature CommunicationsPeer-reviewed·Dec 30, 2024